OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00078256

Guangdong Highsun Meida New Materials Co Ltd

Commodity ChemicalsVerified

The company's capital structure is characterized by a debt-to-equity ratio of 0.4, indicating a relatively conservative leverage position. However, its liquidity is rated as medium, and the free cash flow is negative at -920.58 million CNY, suggesting that the company is not generating sufficient cash from operations to fund its capital expenditures or reduce debt. The operating cash flow is also negative at -1.14 million CNY, further highlighting the company's cash flow challenges. Profitability is a significant concern, with a return on equity of -9.45% and a return on assets of -4.63%, both well below the typical performance of firms in the Commodity Chemicals industry. The company reported a net loss of 153.41 million CNY and an operating loss of 169.31 million CNY, indicating that it is not currently generating profits from its core operations. These figures suggest that the company is underperforming relative to industry norms and may be facing operational inefficiencies or pricing pressures. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic conditions and regulatory changes in China. The absence of detailed segment reporting limits the ability to assess the performance of different product lines or geographic regions. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a continuation of the negative trends, with no clear indication of a turnaround in the next fiscal year. The company's capital expenditures are substantial at 835.09 million CNY, but without a corresponding increase in revenue or profitability, these investments may not yield positive returns. The company's ability to grow will depend on its capacity to improve operational efficiency and secure new markets or customers. The company faces several risk factors, including liquidity constraints and the potential for dilution. The risk assessment indicates a low probability of dilution in the near term, but the company's negative free cash flow and high capital expenditures could necessitate additional financing in the future. The risk of dilution is further compounded by the company's need to fund ongoing operations and capital projects. The company's liquidity risk is moderate, but the negative net cash position after subtracting total debt is a red flag. Recent events, including the company's latest financial filings, indicate ongoing financial stress. The company has not disclosed any major strategic initiatives or new product launches that could drive future growth. The absence of positive developments in the recent transcripts or filings suggests that the company is not currently in a position to capitalize on new opportunities or address its financial challenges.

30-day price · 000782(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyGuangdong Highsun Meida New Materials Co Ltd
Ticker000782.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Guangdong Highsun Meida New Materials Co Ltd is a Chinese chemical manufacturer that produces commodity chemicals and generates revenue primarily through the sale of chemical products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92.

The company's capital structure is characterized by a debt-to-equity ratio of 0.4, indicating a relatively conservative leverage position. However, its liquidity is rated as medium, and the free cash flow is negative at -920.58 million CNY, suggesting that the company is not generating sufficient cash from operations to fund its capital expenditures or reduce debt. The operating cash flow is also negative at -1.14 million CNY, further highlighting the company's cash flow challenges. Profitability is a significant concern, with a return on equity of -9.45% and a return on assets of -4.63%, both well below the typical performance of firms in the Commodity Chemicals industry. The company reported a net loss of 153.41 million CNY and an operating loss of 169.31 million CNY, indicating that it is not currently generating profits from its core operations. These figures suggest that the company is underperforming relative to industry norms and may be facing operational inefficiencies or pricing pressures. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic conditions and regulatory changes in China. The absence of detailed segment reporting limits the ability to assess the performance of different product lines or geographic regions. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a continuation of the negative trends, with no clear indication of a turnaround in the next fiscal year. The company's capital expenditures are substantial at 835.09 million CNY, but without a corresponding increase in revenue or profitability, these investments may not yield positive returns. The company's ability to grow will depend on its capacity to improve operational efficiency and secure new markets or customers. The company faces several risk factors, including liquidity constraints and the potential for dilution. The risk assessment indicates a low probability of dilution in the near term, but the company's negative free cash flow and high capital expenditures could necessitate additional financing in the future. The risk of dilution is further compounded by the company's need to fund ongoing operations and capital projects. The company's liquidity risk is moderate, but the negative net cash position after subtracting total debt is a red flag. Recent events, including the company's latest financial filings, indicate ongoing financial stress. The company has not disclosed any major strategic initiatives or new product launches that could drive future growth. The absence of positive developments in the recent transcripts or filings suggests that the company is not currently in a position to capitalize on new opportunities or address its financial challenges.
Key takeaways
  • The company is currently unprofitable, with a net loss of 153.41 million CNY and an operating loss of 169.31 million CNY.
  • The company's liquidity is rated as medium, and it is not generating positive free cash flow, which is a concern for its financial stability.
  • The company's return on equity and return on assets are both negative, indicating poor profitability and asset utilization.
  • The company's capital expenditures are high, but without a corresponding increase in revenue or profitability, these investments may not yield positive returns.
  • The company's revenue is concentrated in a single business segment, increasing its exposure to regional economic conditions and regulatory changes in China.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.46B
Gross profit$37.9M
Operating income-$169.3M
Net income-$153.4M
R&D
SG&A
D&A
SBC
Operating cash flow-$1.1M
CapEx-$835.1M
Free cash flow-$920.6M
Total assets$3.31B
Total liabilities$1.69B
Total equity$1.62B
Cash & equivalents
Long-term debt$645.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$2.46B-$169.3M-$153.4M-$920.6M
FY-1$3.25B-$80.2M-$70.2M-$57.1M
FY-2$2.82B-$156.3M-$142.7M-$351.4M
FY-3$2.91B-$59.2M-$55.2M-$65.0M
FY-4$3.32B$53.2M$56.3M$95.1M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$3.31B$1.62B
FY-1$2.92B$1.78B
FY-2$3.40B$1.26B
FY-3$3.15B$1.42B
FY-4$3.15B$1.49B
PeriodOCFCapExFCFSBC
FY0-$1.1M-$835.1M-$920.6M
FY-1-$348.9M-$48.5M-$57.1M
FY-2-$395.3M-$237.8M-$351.4M
FY-3-$365.2M-$46.6M-$65.0M
FY-4$24.5M-$15.5M$95.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$631.8M-$5.4M-$5.4M
FQ-1$647.5M-$111.0M-$96.4M
FQ-2$591.9M-$20.2M-$20.4M
FQ-3$588.8M-$39.3M-$37.9M
FQ-4$629.1M$1.3M$1.2M
FQ-5$838.5M-$66.4M-$56.8M
FQ-6$794.8M-$3.0M-$3.0M
FQ-7$848.6M-$2.9M-$2.9M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$3.79B$1.62B$539.0M
FQ-1$3.31B$1.62B
FQ-2$3.04B$1.72B$390.2M
FQ-3$2.99B$1.74B
FQ-4$3.07B$1.78B$613.2M
FQ-5$2.92B$1.78B
FQ-6$3.07B$1.83B$387.5M
FQ-7$3.05B$1.84B
PeriodOCFCapExFCFSBC
FQ0-$352.6M-$286.6M
FQ-1-$1.1M-$835.1M
FQ-2-$87.7M-$370.0M
FQ-3-$268.5M-$190.5M
FQ-4-$331.6M-$56.0M
FQ-5-$348.9M-$48.5M
FQ-6-$219.5M-$7.5M
FQ-7-$201.0M-$2.9M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.62B
Net cash-$645.6M
Current ratio1.2
Debt/Equity0.4
ROA-4.6%
ROE-9.4%
Cash conversion1.0%
CapEx/Revenue-34.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000782Activity
Op margin-6.9%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-6.2%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin1.5%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-34.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity40.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 03:31 UTCJob: e4bb9ecb